Duchenne Muscular Dystrophy (DMD) Clinical Trials

23 recruitingLast updated: July 25, 2026

There are 23 actively recruiting duchenne muscular dystrophy (dmd) clinical trials across 12 countries. Studies span Not Applicable, Phase 1, Early Phase 1, Phase 2, Phase 3. Top locations include Shanghai, Shanghai Municipality, China, Oxford, United Kingdom, Liège, Belgium. Updated daily from ClinicalTrials.gov.


Duchenne Muscular Dystrophy (DMD) Trials at a Glance

23 actively recruiting trials for duchenne muscular dystrophy (dmd) are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Shanghai, Oxford, and Liège. Lead sponsors running duchenne muscular dystrophy (dmd) studies include Entrada Therapeutics, Inc., Shanghai Jiao Tong University School of Medicine, and Vanderbilt University Medical Center.

Browse duchenne muscular dystrophy (dmd) trials by phase

Treatments under study

About Duchenne Muscular Dystrophy (DMD) Clinical Trials

Looking for clinical trials for Duchenne Muscular Dystrophy (DMD)? There are currently 23 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Duchenne Muscular Dystrophy (DMD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Duchenne Muscular Dystrophy (DMD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Phase 1

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center10 enrolled1 locationNCT07172971
Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

Becker muscular dystrophyCardiomyopathyDuchenne Muscular Dystrophy (DMD)+1 more
Vanderbilt University Medical Center1,000 enrolled9 locationsNCT07674758
Recruiting

A Remote Study Using Technology to Assess Outcomes in DMD

Duchenne Muscular Dystrophy (DMD)
University of Oxford60 enrolled1 locationNCT07423026
Recruiting

Duchenne Electronic Health Record Study

Becker muscular dystrophyDuchenne Muscular Dystrophy (DMD)Dystrophinopathy+1 more
The Duchenne Registry2,500 enrolled10 locationsNCT07609394
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled15 locationsNCT07038824
Recruiting
Not Applicable

The Effect of Virtual Reality Applications on Upper Extremity Functions in Patients With Duchenne Muscular Dystrophy

Virtual RealityDuchenne Muscular Dystrophy (DMD)
Istanbul University36 enrolled1 locationNCT07039799
Recruiting
Early Phase 1

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd9 enrolled1 locationNCT07188012
Recruiting

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
University of Rochester105 enrolled1 locationNCT07092540
Recruiting

Invasive Home Ventilation in Denmark

Spinal Cord Injuries (SCI)Neuromuscular Diseases (NMD)MSA - Multiple System Atrophy+5 more
Rigshospitalet, Denmark450 enrolled1 locationNCT07467187
Recruiting
Not Applicable

Urinary Titin Biomarker in DMD

Duchenne Muscular Dystrophy (DMD)Becker's Muscular Dystrophy (BMD)
Children's Hospital of Philadelphia50 enrolled1 locationNCT07332013
Recruiting

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy Type 3
Columbia University106 enrolled3 locationsNCT06839469
Recruiting

DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies

Becker muscular dystrophyCardiomyopathyDuchenne Muscular Dystrophy (DMD)
Aristotle University Of Thessaloniki65 enrolled1 locationNCT07515235
Recruiting
Phase 1Phase 2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled14 locationsNCT07037862
Recruiting
Phase 1

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Duchenne Muscular Dystrophy (DMD)
Grünenthal GmbH24 enrolled1 locationNCT07347548
Recruiting
Not Applicable

Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening

Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy (SMA)
Centre Hospitalier Universitaire de Liege100 enrolled1 locationNCT07286565
Recruiting
Not Applicable

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

Cerebral Palsy (CP)Duchenne Muscular Dystrophy (DMD)Spinal Muscular Atrophy (SMA)
University of Copenhagen8 enrolled1 locationNCT07254988
Recruiting
Not Applicable

Fear of Falling in Muscular Dystrophy

RehabilitationMuscular DystrophiesFear of Falling+1 more
Universita di Verona100 enrolled1 locationNCT07129954
Recruiting

DMD Voice: Qualitative Interviews With Patients and Caregivers

Duchenne Muscular Dystrophy (DMD)
Red Nucleus Enterprise Solutions, LLC68 enrolled1 locationNCT06925269
Recruiting
Early Phase 1

Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06900049